Literature DB >> 6744654

Pseudo-lymphoma associated with carbamazepine.

D Shuttleworth, R A Graham-Brown, A J Williams, A C Campbell, H Sewell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6744654     DOI： 10.1111/j.1365-2230.1984.tb00828.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  7 in total

Review 1.  Anticonvulsant hypersensitivity syndrome in children: incidence, prevention and management.

Authors:  Alberto Verrotti; Daniela Trotta; Carmela Salladini; Francesco Chiarelli
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.

Authors:  S R Knowles; L E Shapiro; N H Shear
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

3.  Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.

Authors:  N H Shear; S P Spielberg
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

4.  Hypersensitivity to carbamazepine presenting as pseudolymphoma.

Authors:  P Yates; G Stockdill; M McIntyre
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

Review 5.  Immunological adverse effects of anticonvulsants. What is their clinical relevance?

Authors:  F De Ponti; S Lecchini; M Cosentino; C M Castelletti; A Malesci; G M Frigo
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

6.  Coexistent dermatofibrosarcoma protuberans and anticonvulsant-induced cutaneous lymphoid hyperplasia: diagnostic challenge.

Authors:  Melinda B Chu; Maulik Dhandha; Aibing Guo
Journal:  BMJ Case Rep       Date:  2013-12-04

7.  Multifocal and recurrent cutaneous pseudolymphoma associated with lamotrigine and review of the literature.

Authors:  Soroush Kazemi; Elanee Simmons; Maija Kiuru; Danielle M Tartar
Journal:  JAAD Case Rep       Date:  2022-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.